Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ENHANCE EFS: Early Feasibility Study (EFS) of the Nyra Cardiac Leaflet Enhancer (CARLEN) System

NCT07503236 is registered in ClinicalTrials.gov with Nyra Medical, Inc. as lead sponsor.

NCT NCT07503236
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07503236 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ENHANCE EFS: Early Feasibility Study (EFS) of the Nyra Cardiac Leaflet Enhancer (CARLEN) System
Lead sponsor
Nyra Medical, Inc.
Phase
Not applicable
Overall status
Recruiting
Start date
July 2, 2026
Completion date
December 31, 2032
Enrollment
30 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

mitral regurgitation functional